http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
논문 : 한옥 생산성 향상을 위한 설계지원 방안에 관한 연구 실무 -부재가공 프로세스 분석을 중심으로-
이현우 ( Hyun Woo Lee ),정성원 ( Sung Won Jung ),전한종 ( Han Jong Jun ) 디자인융복합학회 2012 디자인융복합연구 Vol.11 No.5
기존 한옥의 계승을 위한 관련 연구가 진행되고 있으나, 한옥 보급에는 실용성을 띄지 못하고 있다. 이는 한옥 시공기술의 복잡성과 자재 생산기술 부족으로 인한 제한적 범위 내에서 공사가 진행됨에 따라 높은 공사비를 원인으로 꼽을 수 있다. 이에 따라 현재 전통 한옥이 가진 정체성을 살리고 현시대에 보급될 수 있는 신 한옥으로의 진화를 위해 부재간의 연관을 분석하고 조립하는 방식을 지식으로 구성하고 디지털 모델링을 함으로써 공사비 절감이 가능케 하는 방법 등이 연구되고 있다. 본 연구에서는 한옥 설계자를 고려한 효율적인 부재 가공 정보 지원을 목표로 한옥 부재 실무 가공 분석을 통해 경제성, 시공성을 파악하고 최적화 방안을 위한 한옥 부재 제작 CNC 시뮬레이션을 통해 효율적인 가공 프로세스의 발전 가능성을 예측하여 최적화된 부재가공 정보를 제안하고 이를 기반으로 한옥 수요자들을 위한 설계지원 방법에 대한 구체적인 방안을 제시함으로써 한옥의 생상성 향상에 기여하고자 한다. There have been a lot of studies about the Han-ok, the Korean-style house, in perspective of the inheritage of existing ones, but there are no practicality in the supply of Han-ok. The cause is considered to exist in the complexity of Han-ok and the techniques required to manufacture its components and in the relatively higher construction expenses in the process which is within restricted range. On the contrary, in order to preserve the identity of traditional Han-ok and encourage the evolution to create a new Han-ok that can be supplied to the present period, there has been studies that analyzes the connection between sub-components and assemble them into a digital model which can possibly decrease the expenses spent on construction. The research`s objective is to provide valuable information for Han-ok designers, which contains methods on manufacturing sub-components effectively. Furthermore, by analyzing the current manufacturing method`s workability and economic feasibility, the research can obtain an optimum alternative for improving Han-ok`s production. Also by using CNC simulation, the possibility of an effective production can be predicted, as well as the information that can lead to the optimum method for an efficient sub-component manufacturing and suggest a specific resolution which can also affect on the improvement of Han-ok productivity.
( Ji Yong Kim ),( Jai Sung Lee ),( Yong Seok Han ),( Jun Hee Lee ),( Inhyu Bae ),( Yeo Min Yoon ),( Sang Mo Kwon ),( Sang Hun Lee ) 한국응용약물학회 2015 Biomolecules & Therapeutics(구 응용약물학회지) Vol.23 No.6
Human mesenchymal stem cells (MSCs) have been used in cell-based therapy to promote revascularization after peripheral or myocardial ischemia. High levels of reactive oxygen species (ROS) are involved in the senescence and apoptosis of MSCs, causing defective neovascularization. Here, we examined the effect of the natural antioxidant lycopene on oxidative stress-induced apoptosis in MSCs. Although H2O2 (200 mM) increased intracellular ROS levels in human MSCs, lycopene (10 μmM) pretreatment suppressed H2O2-induced ROS generation and increased survival. H2O2-induced ROS increased the levels of phosphorylated p38 mitogen activated protein kinase (MAPK), Jun-N-terminal kinase (JNK), ataxia telangiectasia mutated (ATM), and p53, which were inhibited by lycopene pretreatment. Furthermore, lycopene pretreatment decreased the expression of cleaved poly (ADP ribose) polymerase-1 (PARP-1) and caspase-3 and increased the expression of B-cell lymphoma 2 (Bcl-2) and Bcl-2-associated X protein (Bax), which were induced by H2O2 treatment. Moreover, lycopene significantly increased manganese superoxide dismutase (MnSOD) expression and decreased cellular ROS levels via the PI3K-Akt pathway. Our findings show that lycopene pretreatment prevents ischemic injury by suppressing apoptosis-associated signal pathway and enhancing anti-oxidant protein, suggesting that lycopene could be developed as a beneficial broad-spectrum agent for the successful MSC transplantation in ischemic diseases.
Kim, Ji Yong,Lee, Jai-Sung,Han, Yong-Seok,Lee, Jun Hee,Bae, Inhyu,Yoon, Yeo Min,Kwon, Sang Mo,Lee, Sang Hun The Korean Society of Applied Pharmacology 2015 Biomolecules & Therapeutics(구 응용약물학회지) Vol.23 No.6
Human mesenchymal stem cells (MSCs) have been used in cell-based therapy to promote revascularization after peripheral or myocardial ischemia. High levels of reactive oxygen species (ROS) are involved in the senescence and apoptosis of MSCs, causing defective neovascularization. Here, we examined the effect of the natural antioxidant lycopene on oxidative stress-induced apoptosis in MSCs. Although $H_2O_2$ ($200{\mu}M$) increased intracellular ROS levels in human MSCs, lycopene ($10{\mu}M$) pretreatment suppressed $H_2O_2$-induced ROS generation and increased survival. $H_2O_2$-induced ROS increased the levels of phosphorylated p38 mitogen activated protein kinase (MAPK), Jun-N-terminal kinase (JNK), ataxia telangiectasia mutated (ATM), and p53, which were inhibited by lycopene pretreatment. Furthermore, lycopene pretreatment decreased the expression of cleaved poly (ADP ribose) polymerase-1 (PARP-1) and caspase-3 and increased the expression of B-cell lymphoma 2 (Bcl-2) and Bcl-2-associated X protein (Bax), which were induced by $H_2O_2$ treatment. Moreover, lycopene significantly increased manganese superoxide dismutase (MnSOD) expression and decreased cellular ROS levels via the PI3K-Akt pathway. Our findings show that lycopene pretreatment prevents ischemic injury by suppressing apoptosis-associated signal pathway and enhancing anti-oxidant protein, suggesting that lycopene could be developed as a beneficial broad-spectrum agent for the successful MSC transplantation in ischemic diseases.
N-acetylcysteine stimulates osteoblastic differentiation of mouse calvarial cells
Jun, Ji Hae,Lee, Sun-Hwan,Kwak, Han Bok,Lee, Zang Hee,Seo, Sang-Beum,Woo, Kyung Mi,Ryoo, Hyun-Mo,Kim, Gwan-Shik,Baek, Jeong-Hwa Wiley Subscription Services, Inc., A Wiley Company 2008 Journal of cellular biochemistry Vol.103 No.4
<P>Estrogen deficiency causes osteoporosis via increased generation of reactive oxygen species (ROS), and thus, antioxidants may prove to be the effective therapeutic candidates. We examined the effects of the antioxidant N-acetylcysteine (NAC) on osteoblastic differentiation in mouse calvarial cells. NAC (10–30 mM) enhanced alkaline phosphatase activity, mRNA expression of osteoblast differentiation-associated genes and mineralized nodule formation. It also increased expression of bone morphogenetic proteins-2, -4, and -7. The osteogenic activity of NAC was partially reduced by inhibition of glutathione synthesis. Since caffeic acid phenethyl ester did not stimulate osteoblast differentiation, it is unlikely that ROS scavenging activity of NAC is sufficient for osteogenic activity. We observed that NAC suppressed small GTPase RhoA activity and activation of RhoA by Pasteurella multocida toxin suppressed the osteogenic activity of NAC. These results suggest that NAC might exert its osteogenic activity via increased glutathione synthesis and inhibition of RhoA activation. J. Cell. Biochem. 103: 1246–1255, 2008. © 2007 Wiley-Liss, Inc.</P>
Sung, Hyeran,Chul Han, Kyung,Chul Kim, Jun,Wan Oh, Ki,Su Yoo, Hwan,Tae Hong, Jin,Bok Chung, Youn,Lee, Chong-kil,Lee, Kyung S.,Song, Sukgil ELSEVIER 2005 FEMS YEAST RESEARCH Vol.5 No.10
<P><B>Abstract</B></P><P>Functional analysis of genes from <I>Saccharomyces cerevisiae</I> has been the major goal after determination of genome sequences. Even though several tools for molecular-genetic analyses have been developed, only a limited number of reliable genetic tools are available to support functional assay at protein level. Epitope tagging is a powerful tool for detecting, purifying, and functional studying of proteins. But systematic tagging systems developed with integration vectors are not available. Here, we have constructed a set of integration vectors allowing a translational fusion of interested proteins to the four different epitope tags (HA, Myc, Flag, and GFP). To confirm function and expression of C-terminal-tagged proteins, we used Cdc11, a component of the septin filament that encircles the mother bud neck and consists of five major proteins: Cdc3, Cdc10, Cdc11, Cdc12, and Sep7. The tagged version of Cdc11 expressed under its endogenous promoter was found to be physiologically functional, as evidenced by localization at the neck and suppression of the growth defect associated with the temperature-sensitive mutation of <I>cdc11-6</I>. The expressed proteins were efficiently detected with antibodies against Cdc11 or the epitopes. When immunoprecipitated with anti-Myc antibody, each septin protein tagged with Myc was effectively copurified with other septin components, indicating formation of a stable septin complex. Because the modules of the tags were located under the same array of eighteen restriction sites on integration vectors containing four different markers (<I>HIS3</I>, <I>TRP1</I>, <I>LEU2</I>, or <I>URA3</I>), this tagging system provides efficient multiple tagging and stable expression of a gene of interest.</P>
Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases
Han Ah Lee,Young Chang,Pil Soo Sung,Eileen L. Yoon,Hye Won Lee,Jeong-Ju Yoo,Young-Sun Lee,Jihyun An,Do Seon Song,Young Youn Cho,Seung Up Kim,Yoon Jun Kim 대한간학회 2022 Clinical and Molecular Hepatology(대한간학회지) Vol.28 No.3
The global burden of chronic liver disease (CLD) is substantial. Due to the limited indication of and accessibility to antiviral therapy in viral hepatitis and lack of effective pharmacological treatment in nonalcoholic fatty liver disease, the beneficial effects of antidiabetics and non–antidiabetics in clinical practice have been continuously investigated in patients with CLD. In this narrative review, we focused on non-antidiabetic drugs, including ursodeoxycholic acid, silymarin, dimethyl- 4,4’-dimethoxy-5,6,5’,6’-dimethylenedixoybiphenyl-2,2’-dicarboxylate, L-ornithine L-aspartate, branched chain amino acids, statin, probiotics, vitamin E, and aspirin, and summarized their beneficial effects in CLD. Based on the antioxidant, anti-inflammatory properties, and regulatory functions in glucose or lipid metabolism, several non–antidiabetic drugs have shown beneficial effects in improving liver histology, aminotransferase level, and metabolic parameters and reducing risks of hepatocellular carcinoma and mortality, without significant safety concerns, in patients with CLD. Although the effect as the centerpiece management in patients with CLD is not robust, the use of these non-antidiabetic drugs might be potentially beneficial as an adjuvant or combined treatment strategy.